i've been reading & re-reading the prelim trial results and various research reports and for the life of me i cannot find data relating to the other 8 trial patients that reached the half way mark.
the Co reported that 3/11 had a 50% or higher reduction in proteinuria over and above standard of care...that's great...but what about the other 8? why was that not reported? even an average for those 8? how about an average for the 11 total?
can anyone shed some light or direct me to more detailed info? i recall someone on here attempting to break down a hypothetical average, but i would prefer having access to the actual figures...that's of course if the Co has actually released them.
DXB Price at posting:
0.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)